查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1968394

瓣环成形系统市场－全球产业规模、份额、趋势、机会和预测：按应用、最终用途、地区和竞争对手划分，2021-2031年

Annuloplasty System Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球瓣环成形术系统市场预计将从 2025 年的 4.8921 亿美元成长到 2031 年的 6.8575 亿美元，复合年增长率达到 5.79%。

这些系统作为植入式假体，用于心臟手术中重建和再形成心臟瓣膜环，恢復瓣膜的正常功能并防止逆流。市场成长趋势主要受全球人口老化以及需要手术介入的瓣膜性心臟病病例增加的双重驱动。此外，优先选择瓣膜修復而非瓣膜置换的趋势（主要目的是使患者摆脱终身抗凝血治疗）也成为推动产业成长的主要动力。根据美国心臟协会估计，到2024年，全球非风湿性退化性二尖瓣疾病的盛行率将达到约1,550万例，凸显了对有效修復方案的巨大需求。

市场概览
预测期 2027-2031
市场规模：2025年 4.8921亿美元
市场规模：2031年 6.8575亿美元
复合年增长率：2026-2031年 5.79%
成长最快的细分市场 二尖瓣修復
最大的市场 北美洲

限制其更广泛市场应用的主要障碍在于有效实施瓣环成形术所需的高超外科技术。此类手术的技术复杂性要求外科医生接受广泛的培训并累积丰富的经验，因此，这些先进的修復方案仅限于专业的大型医疗机构，且在医疗发展中地区难以普及。这种对专业技术的要求造成了瓶颈，阻碍了该技术的广泛应用，使其无法在缺乏必要医疗基础设施的地区充分发挥潜力。

市场驱动因素

二尖瓣和三尖瓣逆流的盛行率不断上升，尤其是在老年人中，是推动市场扩张的主要动力。随着全球老年人口的增长，退化性瓣膜疾病的发生率也随之增加，因此，有效治疗以控制症状和预防心臟衰竭已成为亟待解决的问题。这种人口结构的变化催生了对旨在恢復瓣膜原有结构的瓣环成形术系统的强劲需求。 2025年11月发表于《美国心臟协会杂誌》（AHA 日誌）的一项题为「老年人三尖瓣逆流的盛行率、临床相关性和预后影响」的研究估计，一般人群中中重度三尖瓣逆流的盛行率为3%，且该数值老龄化增长而显着增加。

同时，微创和经导管瓣环成形术系统的技术进步正在从根本上改变治疗格局，为开胸手术提供了切实可行的替代方案。基于导管的输送系统的创新使得即使在高风险患者中也能实现精准植入，从而扩大了目标患者群体，并加速了已开发市场的普及。这种创新的快速成长也体现在产业领导者的财务表现中。例如，2025年1月，雅培公司报告称，其结构性心臟病业务部门2024年全年销售额成长17%，达到22.5亿美元，这主要得益于新型修復技术的应用。同样，2025年，爱德华生命科学公司宣布，其经导管二尖瓣和三尖瓣治疗业务部门2024年第四季度销售额增长88%，达到1.05亿美元，这表明这些先进治疗方法正在迅速普及。

市场挑战

瓣环成形术术所需的高度专业化的外科技术是全球瓣环成形术系统市场成长的主要障碍。瓣膜修復比瓣膜置换术技术更为复杂，要求外科医师具备精湛的技能，才能精确重建瓣环并恢復其生理功能。这种陡峭的学习曲线限制了合格医生的数量，导致此类手术集中在病例量大的专科医疗中心。因此，许多医院，尤其是在新兴市场和病例量较小的医疗机构，由于缺乏复杂修復所需的人员，不得不选择瓣膜置换术，这阻碍了瓣环成形术装置的普及。

人员短缺是限制市场扩张的主要瓶颈，阻碍了市场拓展以应对日益增长的瓣膜性心臟病需求。外科医师数量无法跟上患者需求的成长速度，直接限制了瓣环成形术术的发展。根据美国医学院协会 (AAMC) 2024 年的预测，到 2036 年，外科专家的缺口将达到 10,100 至 19,900 人。高素质外科医生的供应与临床干预需求之间日益扩大的差距将限制市场扩张，因为如果没有足够的合格用户，该行业就无法有效地部署其技术。

市场趋势

机器人辅助瓣膜修復平台的日益普及，克服了传统微创手术在视野和操作性方面的局限性，显着影响着市场动态。这些系统使外科医生能够透过微小切口高精度地完成复杂的瓣环成形术，有效弥合了开胸手术和微创手术疗效之间的差距。从应用指标来看，这些先进外科技术的日益普及显而易见。根据直觉外科公司（Intuitive Surgical）于2025年1月发布的2024年第四季财报，全球达文西手术数量较2023年第四季成长约18%，反映出机器人技术在一般外科和心臟外科领域的快速应用。

同时，将3D列印技术应用于病患特异性器械客製化和术前规划，正成为瓣环成形术流程中的关键环节。透过利用患者影像数据产生解剖学上精确的模型，临床医生可以优化环的尺寸，并在术前模拟植入的位置，从而减少术中误差，提高修復体的长期耐久性。这种向个人化医疗製造的转变正在推动相关生态系统的显着成长。根据MaterialEyes于2025年2月发布的2024年第四季及全年财报，该公司医疗保健业务部门2024年全年营收成长了14.8%，反映出复杂临床手术中对增材製造解决方案的需求日益增长。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球瓣环成形系统市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依应用领域（二尖瓣修补、三尖瓣修补、主动脉瓣修补）
    • 依最终使用者（医院、门诊手术中心等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美瓣环成形系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲瓣环成形系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区瓣环成形系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章 中东和非洲瓣环成形系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲瓣环成形系统市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球瓣环成形系统市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Medtronic Plc
  • Abbott Laboratories, Inc.
  • Edwards Lifesciences Corporation
  • Corcym Group
  • Labcor Laboratorios Ltda
  • Affluent Medical SA
  • Valcare Medical
  • Braile Biomedica
  • LivaNova PLC
  • Micro Interventional Devices, Incorporated

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 27473

The Global Annuloplasty System Market is projected to expand from USD 489.21 Million in 2025 to USD 685.75 Million by 2031, achieving a compound annual growth rate (CAGR) of 5.79%. These systems serve as implantable prosthetic devices used in cardiac surgery to reconstruct and reshape the heart valve annulus, thereby restoring proper valve function and preventing regurgitation. The market's upward trajectory is heavily driven by the aging global population and a concurrent rise in valvular heart conditions that require surgical intervention. Furthermore, the clinical preference for valve repair over replacement-primarily to spare patients from lifelong anticoagulation therapy-acts as a major catalyst for industry growth. According to the American Heart Association, the global prevalence of nonrheumatic degenerative mitral valve disease was approximately 15.5 million cases in 2024, highlighting the substantial demand for effective repair solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 489.21 MIllion
Market Size 2031USD 685.75 MIllion
CAGR 2026-20315.79%
Fastest Growing SegmentMitral Valve Repair
Largest MarketNorth America

A significant barrier restricting broader market adoption is the high level of surgical expertise required to perform effective annuloplasty procedures. The technical complexity of these operations necessitates extensive surgeon training and experience, which confines the availability of these advanced repair options to specialized, high-volume centers and limits accessibility in developing healthcare regions. This requirement for specialized skills creates a bottleneck that hinders widespread implementation, preventing the technology from reaching its full potential in areas lacking the necessary medical infrastructure.

Market Driver

The escalating prevalence of mitral and tricuspid valve regurgitation, particularly among the aging demographic, acts as a primary engine for market expansion. As the global geriatric population grows, the incidence of degenerative valvular pathologies rises, creating a critical need for effective repair interventions to manage symptoms and prevent heart failure. This demographic shift sustains a strong demand for annuloplasty systems designed to restore native valve geometry. According to a study published in AHA Journals in November 2025 titled 'Prevalence, Clinical Correlates, and Prognostic Impact of Tricuspid Regurgitation in Older Adults,' the estimated prevalence of moderate to severe tricuspid regurgitation in the general population is 3%, a figure that increases significantly with age.

Simultaneously, technological advancements in minimally invasive and transcatheter annuloplasty systems are fundamentally reshaping the treatment landscape by offering viable alternatives to open-heart surgery. Innovations in catheter-based delivery systems enable precise implant positioning in high-risk patients, thereby expanding the addressable patient pool and accelerating adoption rates in developed markets. This surge in innovation is reflected in the financial performance of key industry players. For instance, Abbott reported in January 2025 that their Structural Heart unit sales increased by 17% for the full year 2024, reaching $2.25 billion, largely driven by the adoption of new repair technologies. Similarly, Edwards Lifesciences noted in 2025 that sales for their Transcatheter Mitral and Tricuspid Therapies division grew 88% in the fourth quarter of 2024 to $105 million, evidencing the rapid uptake of these advanced therapies.

Market Challenge

The high level of specialized surgical expertise required to perform annuloplasty procedures constitutes a substantial barrier hindering the growth of the Global Annuloplasty System Market. Valve repair is technically more demanding than valve replacement, requiring surgeons to possess advanced skills to precisely reconstruct the annulus and restore physiological function. This steep learning curve limits the number of qualified operators, resulting in a concentration of these procedures solely in high-volume, specialized medical centers. Consequently, many hospitals, particularly in emerging markets or lower-volume facilities, default to valve replacement surgeries simply because they lack the requisite personnel to perform complex repairs, thereby stifling the adoption of annuloplasty devices.

This workforce constraint creates a significant bottleneck that prevents the market from meeting the rising prevalence of valvular disease. The inability to scale the surgical workforce at the same pace as patient demand directly caps the procedural volume for annuloplasty systems. According to projections from the Association of American Medical Colleges in 2024, a shortage of between 10,100 and 19,900 physicians in surgical specialties is anticipated by 2036. This widening gap between the availability of highly trained surgeons and the clinical need for intervention limits market expansion, as the industry cannot deploy its technologies effectively without a sufficient base of capable users.

Market Trends

The increased utilization of robotic-assisted valve repair platforms is significantly influencing market dynamics by overcoming the visualization and dexterity limitations associated with conventional minimally invasive surgery. These systems enable surgeons to perform complex annuloplasty procedures with high precision through small incisions, effectively bridging the gap between open-heart efficacy and less invasive approaches. The expanding footprint of these advanced surgical modalities is evident in adoption metrics; according to Intuitive Surgical's January 2025 report on 'Fourth Quarter 2024 Financial Results,' worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023, reflecting the rapid integration of robotic technologies into general and cardiac surgical practice.

Concurrently, the integration of 3D printing for patient-specific device customization and pre-surgical planning is becoming a critical component of the annuloplasty workflow. By generating anatomically accurate models from patient imaging, clinicians can optimize ring sizing and simulate implant placement prior to the operation, thereby reducing intraoperative errors and improving long-term repair durability. This shift toward personalized medical manufacturing is driving substantial growth in the supporting ecosystem. According to Materialise's February 2025 report on 'Fourth Quarter and Full Year 2024 Results,' revenues from the company's Medical segment grew by 14.8% for the full year 2024, underscoring the rising demand for additive manufacturing solutions in complex clinical interventions.

Key Market Players

  • Medtronic Plc
  • Abbott Laboratories, Inc.
  • Edwards Lifesciences Corporation
  • Corcym Group
  • Labcor Laboratorios Ltda
  • Affluent Medical SA
  • Valcare Medical
  • Braile Biomedica
  • LivaNova PLC
  • Micro Interventional Devices, Incorporated

Report Scope

In this report, the Global Annuloplasty System Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Annuloplasty System Market, By Application

  • Mitral Valve Repair
  • Tricuspid Valve Repair
  • Aortic Valve Repair

Annuloplasty System Market, By End Use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Annuloplasty System Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Annuloplasty System Market.

Available Customizations:

Global Annuloplasty System Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Annuloplasty System Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Mitral Valve Repair, Tricuspid Valve Repair, Aortic Valve Repair)
    • 5.2.2. By End Use (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Annuloplasty System Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Annuloplasty System Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End Use
    • 6.3.2. Canada Annuloplasty System Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End Use
    • 6.3.3. Mexico Annuloplasty System Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End Use

7. Europe Annuloplasty System Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Annuloplasty System Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End Use
    • 7.3.2. France Annuloplasty System Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Annuloplasty System Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Annuloplasty System Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Annuloplasty System Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End Use

8. Asia Pacific Annuloplasty System Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Annuloplasty System Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Annuloplasty System Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End Use
    • 8.3.3. Japan Annuloplasty System Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End Use
    • 8.3.4. South Korea Annuloplasty System Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Annuloplasty System Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End Use

9. Middle East & Africa Annuloplasty System Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Annuloplasty System Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End Use
    • 9.3.2. UAE Annuloplasty System Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End Use
    • 9.3.3. South Africa Annuloplasty System Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End Use

10. South America Annuloplasty System Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Annuloplasty System Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End Use
    • 10.3.2. Colombia Annuloplasty System Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End Use
    • 10.3.3. Argentina Annuloplasty System Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Annuloplasty System Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Medtronic Plc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Abbott Laboratories, Inc.
  • 15.3. Edwards Lifesciences Corporation
  • 15.4. Corcym Group
  • 15.5. Labcor Laboratorios Ltda
  • 15.6. Affluent Medical SA
  • 15.7. Valcare Medical
  • 15.8. Braile Biomedica
  • 15.9. LivaNova PLC
  • 15.10. Micro Interventional Devices, Incorporated

16. Strategic Recommendations

17. About Us & Disclaimer